ARCH Venture Partners XII, LLC bought $5.0M of NMRA
owner at Neumora Therapeutics, Inc.. 1,915,700 shares at an average of $2.61, traded Oct 27, 2025, filed Oct 29, 2025.
Score components
- +12Role10% owner
- +25Trade size$5.0M at market
- +6Relative to holdingsHoldings up 46%
- +8Price context80% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001012975-25-000680, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | POpen-market purchase Common Stockindirect: By ARCH Venture Fund XII, L.P. | +1,915,700 | $2.61 | $5.0M | 6,046,907 | Oct 29, 2025 |
Related signals
Other insiders at Neumora Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora See Remarks | $22k 6,165 shares | -7% | |
| 29Weak | Neumora Therapeutics, Inc. | Paul L Berns See Remarks | $34k 9,819 shares | -0% | |
| 29Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora See Remarks | $307k 114,703 shares | -100% | |
| 61Notable | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC owner | $5.0M 1,915,700 shares | +46% | |
| 69Notable | Neumora Therapeutics, Inc. | Kristina Burow director, owner | $5.0M 1,915,700 shares | +46% | |
| 3Weak | Neumora Therapeutics, Inc. | Daljit Singh Aurora Chief Strategy Officer | $14k 8,565 shares | -9% | |
| 3Weak | Neumora Therapeutics, Inc. | Paul L Berns See Remarks | $23k 13,871 shares | -0% | |
| 23Weak | Neumora Therapeutics, Inc. | Matthew K Fust director | $371k 21,788 shares | -78% | |
| 15Weak | Neumora Therapeutics, Inc. | Robert A. Lenz Head of R&D | $208k 13,823 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.